RE: Observation7 Mar 2023 12:05
a few less bedwetters cum traders on board....just watched again the last couple of interviews...have to say how exciting it will be... if you just take lung cancer alone as a market and how the UK NSC recommended the introduction of targeted lung cancer screening recently. Poland are doing more, see below....We have a simple, cheap finger-prick blood that with a very high correlation can say whether someone has lung cancer or not and whether if they had it are they now in remission. And imagine if the test has an equally high correlation with other cancers and we know this is something already in the pipeline. Imagine an early stage blood test to identify two of the biggest cancers in the world. We really are talking about a multi-billion dollar product. Sadly, we will be taken out long before that.